These weight loss injections are accompanied by a diet and exercise routine for enhanced results
The FDA has identified potential safety concerns involving compounded injectable GHK-Cu, including possible immunogenicity related to peptide aggregation or impurities, and notes that human safety information is limited
65,66 A network meta-analysis ranked SEMA 0.4 mg first in the resolution of MASH among alternative treatments [surface under the cumulative ranking (SUCRA) = 0.89], higher than liraglutide (SUCRA = 0.84) and resmetirom (SUCRA = 0.44)
The study found that 76 in 100 people had coverage for GLP-1 agonists if they had diabetes, while 27 in 100 individuals had coverage for GLP-1 agonists for weight loss alone
Monitor for Side Effects Though rare, some individuals may experience mild dizziness or headaches after a B12 injection
Semaglutide is not a statin and should not be viewed as a cholesterol medication replacement